Positive Impact of Complementary Traditional Chinese Medicine on Symptom Management and Quality of Life in Breast Cancer Patients - Top-Institutions - MDSpire

Positive Impact of Complementary Traditional Chinese Medicine on Symptom Management and Quality of Life in Breast Cancer Patients

  • By

  • Chien-Wei Tseng

  • Ya-Ting Hsu

  • Jing-Shiang Hwang

  • Yao-Jen Chang

  • Hsien-Chang Wu

  • April 20, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Integrative Oncology
    • Breast Cancer
    • Complementary Medicine

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Integrative Medicine
    • Breast Oncology
    • Complementary and Alternative Medicine

  • #3

    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center
    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

    San Francisco, CA

    Key Differentiators

    • Integrative Oncology
    • Breast Cancer Research
    • Complementary Therapies

  • #4

    Shanghai Jiao Tong University School of Medicine – Ruijin Hospital
    Shanghai Jiao Tong University School of Medicine – Ruijin Hospital

    Shanghai, Shanghai

    Key Differentiators

    • Traditional Chinese Medicine
    • Breast Cancer
    • Integrative Oncology

  • #5

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Breast Cancer
    • Integrative Oncology
    • Complementary Medicine

Original Source(s)

Positive Impact of Complementary Traditional Chinese Medicine on Symptom Management and Quality of Life in Breast Cancer Patients

  • by Chien-Wei Tseng, Ya-Ting Hsu, Jing-Shiang Hwang, Yao-Jen Chang, Hsien-Chang Wu

  • April 20, 2026

Related Content

Roswell Park at ASCO 2026: GLP-1s and Aggressive Breast Cancer, CAR T in Older Adults, AI-Informed Benchmarking

The research findings of experts from Roswell Park Comprehensive Cancer Center will be featured during the American Society of Clinical Oncology (ASCO) annual meeting May 29 to June 2 at McCormick Place in Chicago

  • by

  • May 25, 2026

  • 9 min
Longitudinal predictor analysis of pain in breast cancer survivors on aromatase inhibitors—the PAC-WOMAN trial

How Cancer Online Support Groups Work, for Whom, and in What Circumstances: Realist Review